|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net Income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Right of use asset amortization | |||||
| Provision for credit losses | |||||
| Loss on sale of securities available for sale | |||||
| Loss on call of securities held to maturity | |||||
| Gain on sale of mortgage loans | |||||
| (Gain) loss on sale of premises and equipment | |||||
| Gain on sale of OREO | |||||
| OREO write-down | |||||
| Realized/unrealized (gain) loss on equity securities | |||||
| Net amortization of premium on investment securities available for sale | |||||
| Net amortization of premium on investment securities held to maturity | |||||
| Amortization of loan servicing rights | |||||
| Originations and purchases of mortgage loans for sale | |||||
| Proceeds from sale of mortgage loans for sale | |||||
| Mortgage banking derivatives | |||||
| Loan servicing assets | |||||
| Accrued interest receivable | |||||
| Prepaid assets | |||||
| Cash surrender value of life insurance | |||||
| Miscellaneous other assets | |||||
| Deferred income taxes | |||||
| Accrued interest payable | |||||
| Miscellaneous other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Proceeds from sale of investment securities available for sale | |||||
| Proceeds from maturities, calls and paydowns of securities available for sale | |||||
| Proceeds from maturities, calls and paydowns of securities held to maturity | |||||
| Purchase of investment securities available for sale | |||||
| Purchase of investments in other assets | |||||
| Proceeds from distributions of investments in other assets | |||||
| Net change in restricted stock | |||||
| Proceeds from Sale of Restricted Investments | |||||
| Payments to Acquire Restricted Investments | |||||
| Net increase in loans | |||||
| Purchase of premises and equipment | |||||
| Proceeds from sale of premises, equipment and other assets | |||||
| Proceeds from sale of OREO | |||||
| Net cash used by investing activities | |||||
| Cash flows from financing activities | |||||
| Net increase in deposit accounts | |||||
| Net increase (decrease) in federal funds purchased and other short-term borrowings | |||||
| Repayment of long-term borrowings | |||||
| Repurchase of common stock, net | |||||
| Dividends paid on preferred stock (noncontrolling interest) | |||||
| Cash paid for fractional shares | |||||
| Net cash provided by financing activities | |||||
| Increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of year | |||||
| Cash and cash equivalents, end of year | |||||
| Supplemental disclosures of cash flow information | |||||
| Interest paid | |||||
| Income taxes paid | |||||
| Supplemental schedule of non-cash activities | |||||
| Net change in fair value of securities available for sale, net of tax | |||||
| Company financed OREO | |||||
| Loans transferred to foreclosed real estate | |||||
Loading...
